0001558370-24-006279.txt : 20240430 0001558370-24-006279.hdr.sgml : 20240430 20240430163014 ACCESSION NUMBER: 0001558370-24-006279 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240424 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240430 DATE AS OF CHANGE: 20240430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 24897745 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 8-K 1 tmb-20240424x8k.htm 8-K
0000842023false00008420232024-04-242024-04-24

​

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549 

FORM 8-K

​

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 24, 2024

 

BIO-TECHNE CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Minnesota

0-17272

41-1427402

(State or Other Jurisdiction of

Incorporation)

(Commission File Number)

(I.R.S. Employer Identification

Number)

​

 55413

​

614 McKinley Place NE

Minneapolis, Minnesota 55413

(Address of Principal Executive Offices) (Zip Code)

 

(612) 379-8854

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

​

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

TECH

NASDAQ

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

​

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

​

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

​

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

​

☐   Emerging growth company

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

​

 

​

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 24, 2024, Bio-Techne Corporation (the “Company”) temporarily expanded the size of the Board of Directors from ten to eleven members and appointed Dr. Judith Klimovsky to the company's Board of Directors as an independent director.

Judith Klimovsky, M.D., is currently the Executive Vice President and Chief Development Officer at Genmab A/S, a Denmark-based biotechnology company. Before joining Genmab A/S, Dr. Klimovsky held various senior global clinical and research positions at Novartis Oncology, a division of Novartis AG, and Bristol-Meyers Squibb Company. Dr. Klimovsky holds an MD from the Universidad de Buenos Aires.

​

There are no arrangements or understandings between Dr. Klimovsky and any other persons pursuant to which she was selected as a director. Additionally, there are no transactions involving the Company and Dr. Klimovsky that Bio-Techne would be required to report pursuant to Item 404(a) of Regulation S-K.

​

Dr. Klimovsky will be entitled to receive compensation for her Board service in accordance with the company's standard compensation arrangements for non-employee directors, which are described under the caption “Director Compensation” in the company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on September 13, 2023, pro-rated for a partial year of service in accordance with company policy.

​

Dr. Klimovsky will serve on the Science & Technology Committee of the Board of Directors.

​

The Board of Directors also approved a one-year waiver of the mandatory retirement policy for Dr. Roeland Nusse pursuant to the terms of such policy.

​

Item 8.01 Other Events

​

A copy of the press release issued by Bio-Techne Corporation on April 30, 2024, announcing Dr. Klimovsky’s appointment is attached hereto as Exhibit 99.1.

​

​

Item 9.01.      Financial Statements and Exhibits

​

Exhibit No.

Description

99.1

Press Release, dated April 30, 2024, announcing appointment of Dr. Klimovsky as director

​

​

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

​

​

​

​

​

​

​

​

​

​

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BIO-TECHNE CORPORATION

 

 

 

 

 

Date: April 30, 2024

By:

/s/ Shane V. Bohnen

 

 

Shane V. Bohnen

 

 

Senior Vice President, General Counsel and Corporate Secretary

​

​

 

 

​

 EX-99.1 2 tmb-20240424xex99d1.htm EX-99.1 TECHNE CORPORATION RELEASES UNAUDITED SECOND QUARTER

​

EXHIBIT 99.1

​

BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS

Minneapolis, April 30, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors, April 24, 2024. Dr. Klimovsky will serve as a member of the Science and Technology Committee. Following the appointment, the board of Bio-Techne will be temporarily comprised of eleven directors, ten of whom are independent.

Dr. Klimovsky is currently the Executive Vice President and Chief Development Officer at Genmab, an international biotechnology company specialized in the creation and development of antibody therapeutics. Before joining Genmab in 2017, Dr. Klimovsky held various senior global clinical and research positions at Novartis Oncology, a division of Novartis AG, including SVP & Global Head, Oncology Clinical Development. Dr. Klimovsky also served as Regional Medical Director, Latin America for Merck & Co. and held several research and development roles of increasing responsibility at Bristol-Myers Squibb Company. Dr. Klimovsky received her M.D. from the Universidad de Buenos Aires.

Dr. Klimovsky previously (from 2018 to Feb 2024) served as a Director of Bellicum Pharmaceuticals, a company discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors.

“We are pleased to welcome Dr. Klimovsky to our board,” said Bob Baumgartner, Chairman of the Board of Bio-Techne. “She brings tremendous scientific and international experience, including running large development groups at global biopharma companies. She also has extensive experience in Latin America, which will bring important expertise as Bio-Techne continues to expand globally.”

 

About Bio-Techne Corporation (NASDAQ: TECH) 

​
Contact: David Clair, Vice President, Investor Relations & Corporate Development 
david.clair@bio-techne.com  
612-656-4416 

 EX-101.SCH 3 tmb-20240424.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 tmb-20240424_lab.xml EX-101.LAB EX-101.PRE 5 tmb-20240424_pre.xml EX-101.PRE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Document and Entity Information
Apr. 24, 2024
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Apr. 24, 2024
Entity Registrant Name BIO-TECHNE CORPORATION
Entity Incorporation, State or Country Code MN
Entity File Number 0-17272
Entity Tax Identification Number 41-1427402
Entity Address, Address Line One 614 McKinley Place NE
Entity Address, City or Town Minneapolis
Entity Address State Or Province MN
Entity Address, Postal Zip Code 55413
City Area Code 612
Local Phone Number 379-8854
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol TECH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000842023
Amendment Flag false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 1 22 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://tech.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports tmb-20240424.xsd tmb-20240424_lab.xml tmb-20240424_pre.xml tmb-20240424x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tmb-20240424x8k.htm": { "nsprefix": "tech", "nsuri": "http://tech.com/20240424", "dts": { "schema": { "local": [ "tmb-20240424.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "tmb-20240424_lab.xml" ] }, "presentationLink": { "local": [ "tmb-20240424_pre.xml" ] }, "inline": { "local": [ "tmb-20240424x8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://tech.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_4_24_2024_To_4_24_2024_f6BTYwSrA067Kgw4V2M0sA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "tmb-20240424x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_4_24_2024_To_4_24_2024_f6BTYwSrA067Kgw4V2M0sA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "tmb-20240424x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://tech.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001558370-24-006279-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-006279-xbrl.zip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�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end XML 17 tmb-20240424x8k_htm.xml IDEA: XBRL DOCUMENT 0000842023 2024-04-24 2024-04-24 0000842023 false 8-K 2024-04-24 BIO-TECHNE CORPORATION MN 0-17272 41-1427402 614 McKinley Place NE Minneapolis MN 55413 612 379-8854 Common Stock TECH NASDAQ false false false false false